Schedule 13G ownership disclosure

OptimizeRx Corp

Common Stock · CUSIP: 68401U204

Event date: 2025-03-31

Filing-level shares
921,848
Percent of class
4.98%
  • The Vanguard Group

    Shares: 921,848 · Class: 4.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000616
Form type
SCHEDULE 13G/A
Filer
OptimizeRx Corp
CIK
CIK 1448431
Filed
Apr 30, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub